0,982  0,000  UGT1A4 substrate
0,972  0,001  Neurotrophic factor enhancer
0,965  0,001  Cholesterol antagonist
0,960  0,002  Antihypercholesterolemic
0,910  0,005  Apoptosis agonist
0,904  0,005  Antineoplastic (breast cancer)
0,897  0,003  UDP-glucuronosyltransferase substrate
0,872  0,003  Antineoplastic (liver cancer)
0,868  0,008  Antiinflammatory
0,862  0,005  Antileukemic
0,845  0,004  Nitric oxide antagonist
0,841  0,004  Antineoplastic (pancreatic cancer)
0,826  0,006  Antineoplastic (lung cancer)
0,823  0,004  Chemopreventive
0,810  0,005  Alzheimer's disease treatment
0,811  0,006  Antineoplastic (colorectal cancer)
0,809  0,006  Antineoplastic (colon cancer)
0,800  0,003  Proliferative diseases treatment
0,749  0,005  Antineoplastic (glioma)
0,731  0,005  Cardiovascular analeptic
0,726  0,016  CYP3A4 substrate
0,714  0,005  Lipoprotein disorders treatment
0,692  0,004  Antihelmintic
0,693  0,006  Antiparasitic
0,692  0,005  Antineoplastic (brain cancer)
0,703  0,020  Transcription factor NF kappa B inhibitor
0,687  0,004  Antineoplastic (glioblastoma multiforme)
0,674  0,004  Platelet adhesion inhibitor
0,677  0,008  Antineoplastic (cervical cancer)
0,673  0,004  Antipruritic, allergic
0,653  0,005  Antineoplastic (sarcoma)
0,650  0,005  Hypolipemic
0,640  0,007  Cardioprotectant
0,642  0,014  Prostate cancer treatment
0,636  0,009  NOS3 expression inhibitor
0,640  0,013  Antineoplastic (ovarian cancer)
0,640  0,014  Respiratory analeptic
0,630  0,009  Hepatic disorders treatment
0,622  0,003  Neurotrophic factor
0,625  0,007  Apoptosis antagonist
0,617  0,010  Cytotoxic
0,589  0,006  Antineoplastic (lymphoma)
0,589  0,009  Antifungal
0,578  0,005  Antineoplastic (renal cancer)
0,593  0,024  Teratogen
0,594  0,026  TNF expression inhibitor
0,583  0,024  Embryotoxic
0,559  0,005  Prostatic (benign) hyperplasia treatment
0,554  0,004  Psychosexual dysfunction treatment
0,568  0,017  Immunosuppressant
0,558  0,011  Antipyretic
0,563  0,017  Antineoplastic (melanoma)
0,542  0,004  Diabetic nephropathy treatment
0,536  0,008  Antihypertriglyceridemic
0,532  0,004  Dementia treatment
0,531  0,004  Vascular dementia treatment
0,532  0,007  UGT2B4 substrate
0,520  0,003  Sodium/bile acid cotransporter inhibitor
0,523  0,007  Anesthetic general
0,533  0,020  Sensitization
0,515  0,005  Contraceptive
0,521  0,020  Analeptic
0,509  0,018  NOS2 expression inhibitor
0,506  0,020  AR expression inhibitor
0,479  0,004  Antipruritic, non-allergic
0,504  0,039  Antibacterial
0,468  0,005  Antiviral (Influenza A)
0,468  0,007  Prostate disorders treatment
0,497  0,037  Antiprotozoal
0,465  0,007  UGT2B7 substrate
0,486  0,028  Antiprotozoal (Plasmodium)
0,475  0,020  Antineoplastic (non-small cell lung cancer)
0,473  0,018  Hypoglycemic
0,501  0,050  Antidiabetic
0,501  0,050  Cyclophilin D inhibitor
0,474  0,023  Antioxidant
0,454  0,005  Lipocortins synthesis antagonist
0,454  0,009  Hepatoprotectant
0,450  0,005  Liver fibrosis treatment
0,446  0,004  UGT2B9 substrate
0,455  0,026  Cytostatic
0,488  0,065  Caspase 9 stimulant
0,434  0,011  Abortion inducer
0,435  0,021  Platelet antagonist
0,439  0,026  ICAM1 expression inhibitor
0,413  0,000  Cholesterol absorption inhibitor
0,421  0,010  Anesthetic
0,417  0,009  Antiviral (Influenza)
0,429  0,024  Antiamyloidogenic
0,438  0,050  Atherosclerosis treatment
0,393  0,008  Hemostatic
0,399  0,019  Interleukin agonist
0,404  0,024  UGT1A6 substrate
0,385  0,018  UGT1A1 substrate
0,392  0,027  Cardiodepressant
0,387  0,024  Angiogenesis stimulant
0,381  0,024  DNA synthesis inhibitor
0,379  0,027  Amyotrophic lateral sclerosis treatment
0,371  0,030  Antidiabetic symptomatic
0,354  0,016  Thrombolytic
0,344  0,007  Cell adhesion inhibitor
0,342  0,012  UGT2B15 substrate
0,384  0,054  Immunostimulant
0,342  0,015  Interferon gamma antagonist
0,367  0,042  UGT1A9 substrate
0,325  0,005  Beta amyloid protein antagonist
0,360  0,041  Interleukin 2 agonist
0,335  0,017  Antiacne
0,320  0,004  UGT2B10 substrate
0,349  0,035  Amyloid beta aggregation inhibitor
0,316  0,010  Cholesterol synthesis inhibitor
0,303  0,007  Androgen antagonist
0,321  0,027  Muscle relaxant
0,338  0,046  Antineoplastic (multiple myeloma)
0,366  0,075  CYP2C9 substrate
0,292  0,002  Glycine receptor agonist
0,289  0,002  Arachidonic acid antagonist
0,278  0,005  Estrogen agonist
0,273  0,004  Microtubule formation inhibitor
0,280  0,011  Antitussive
0,283  0,019  Growth factor agonist
0,271  0,009  Farnesoid X receptor antagonist
0,316  0,057  Antineoplastic (endocrine cancer)
0,269  0,014  Antifungal enhancer
0,257  0,002  RNA-directed RNA polymerase stimulant
0,254  0,003  Anticholelithogenic
0,277  0,025  Antineoplastic (squamous cell carcinoma)
0,324  0,076  Bone diseases treatment
0,257  0,025  NOS3 expression enhancer
0,257  0,029  Antineoplastic (carcinoma)
0,240  0,015  Antineoplastic antibiotic
0,229  0,009  Growth stimulant
0,217  0,003  UGT2B11 substrate
0,232  0,022  VEGF expression inhibitor
0,218  0,011  Contraceptive female
0,211  0,010  Contraceptive male
0,235  0,035  UGT1A3 substrate
0,202  0,004  Glycine receptor antagonist
0,249  0,055  Carcinogenic
0,197  0,004  Anabolic
0,283  0,090  CYP3A4 inhibitor
0,207  0,015  UGT2B1 substrate
0,202  0,010  Pregnane X receptor agonist
0,262  0,075  Chemoprotective
0,189  0,005  Bile acid receptor antagonist
0,216  0,033  Toxic, respiratory center
0,266  0,083  CYP2C19 substrate
0,273  0,094  Caspase 3 stimulant
0,181  0,003  Na+ K+ transporting ATPase inhibitor
0,284  0,108  Calcium channel activator
0,260  0,085  Antiosteoporotic
0,231  0,059  Mutagenic
0,209  0,038  Phospholipase C inhibitor
0,257  0,099  Metabolic disease treatment
0,179  0,022  Choleretic
0,200  0,045  Hair growth stimulant
0,165  0,011  Aromatase inhibitor
0,222  0,072  RNA-directed DNA polymerase inhibitor
0,154  0,007  Androgen agonist
0,257  0,110  Immunomodulator
0,186  0,044  Insulin secretagoues
0,240  0,099  Antidiabetic (type 2)
0,155  0,014  SULT1E1 substrate
0,188  0,048  ATPase inhibitor
0,158  0,023  Antiinfertility, female
0,138  0,004  Antitreponemal
0,145  0,012  Postmenopausal disorders treatment
0,207  0,079  Antialcoholic
0,145  0,020  Antibiotic
0,250  0,126  Antithrombotic
0,234  0,115  Hypoxia-inducible factor 1 alpha inhibitor
0,161  0,045  Antifungal (Cryptococcus)
0,159  0,044  DNA polymerase I inhibitor
0,142  0,027  Estrogen antagonist
0,119  0,004  Anesthetic inhalation
0,118  0,003  Lipocortins synthesis agonist
0,115  0,003  Glucose-6-phosphate dehydrogenase inhibitor
0,221  0,111  Antineurogenic pain
0,235  0,126  CTGF expression inhibitor
0,239  0,130  Antihypertensive
0,255  0,151  Antiobesity
0,121  0,020  Antiprotozoal activity enhancer
0,178  0,078  Antiviral (Hepatitis)
0,138  0,042  Endometrios treatment
0,164  0,070  Interleukin 6 antagonist
0,157  0,064  Antidiarrheal
0,099  0,009  SULT2A1 substrate
0,119  0,031  Lanosterol 14 alpha demethylase inhibitor
0,110  0,022  Lipase inhibitor
0,090  0,005  Glucocorticoid antagonist
0,135  0,053  Autism spectrum disorders treatment
0,147  0,067  Adenylate cyclase stimulant
0,115  0,038  Estrogen receptor beta antagonist
0,136  0,061  Antihyperlipoproteinemic
0,078  0,008  Pregnane X receptor antagonist
0,126  0,056  Alcohol dehydrogenase substrate
0,144  0,075  Genotoxic
0,083  0,015  Andropause treatment
0,171  0,103  Antimitotic
0,115  0,047  Antineoplastic, alkylator
0,080  0,012  5-Alpha-reductase inhibitor
0,078  0,012  Estrogen receptor alpha agonist
0,139  0,076  Skeletal muscle relaxant
0,150  0,090  Antiviral (Hepatitis C)
0,160  0,103  P-glycoprotein inhibitor
0,090  0,035  Estrogen receptor alpha antagonist
0,102  0,046  Antineoplastic alkaloid
0,073  0,018  Postcoital contraceptive
0,144  0,090  Sigma receptor agonist
0,107  0,056  Sulfotransferase substrate
0,062  0,012  Microtubule stabilization
0,125  0,076  Antihemorrhagic
0,065  0,017  Estrogen receptor beta agonist
0,169  0,124  Antiprotozoal (Leishmania)
0,056  0,012  Farnesoid X receptor agonist
0,049  0,006  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,065  0,023  Acetyl-CoA transferase 2 inhibitor
0,046  0,004  Hedgehog signaling activator
0,127  0,086  Protein kinase stimulant
0,045  0,004  Corticosteroid-like
0,081  0,042  CDC25A inhibitor
0,087  0,048  Acetylcholine nicotinic antagonist
0,053  0,014  Hypogonadism treatment
0,044  0,005  Glucocorticoid agonist
0,106  0,070  Mucolytic
0,150  0,116  Psychostimulant
0,052  0,018  Parathyroid hormone antagonist
0,130  0,097  Antiviral (Herpes)
0,164  0,131  Antineoplastic (lymphocytic leukemia)
0,100  0,068  Expectorant
0,043  0,012  Tubulin agonist
0,060  0,031  Protein 50S ribosomal subunit inhibitor
0,054  0,026  Mineralocorticoid receptor antagonist
0,041  0,013  HMG CoA reductase inhibitor
0,053  0,026  Aldosterone antagonist
0,085  0,058  Transcription factor NF kappa B stimulant
0,033  0,006  Progesterone agonist
0,088  0,062  Actinic keratosis treatment
0,064  0,040  Antimycoplasmal
0,052  0,028  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,062  0,039  Heme oxygenase stimulant
0,075  0,052  SULT1A2 substrate
0,068  0,048  Premenstrual syndrome treatment
0,024  0,005  Vitamin D receptor agonist
0,092  0,073  Antifibrinolytic
0,131  0,113  Melanin inhibitor
0,095  0,079  Toll-Like receptor 4 antagonist
0,172  0,157  Huntington's disease treatment
0,094  0,079  AMP-activated protein kinase stimulant
0,024  0,011  Vitamin D receptor antagonist
0,113  0,100  Liver cirrhosis treatment
0,013  0,002  Transcortin receptor antagonist
0,035  0,025  Progesterone antagonist
0,020  0,011  Apical sodium codependent bile acid transporter inhibitor
0,022  0,014  Estrone sulfatase inhibitor
0,091  0,083  Hedgehog signaling inhibitor
0,175  0,167  Renal disease treatment
0,016  0,010  NMDA receptor phencyclidine site antagonist
0,013  0,007  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,019  0,014  5-Alpha-reductase 2 inhibitor
0,030  0,025  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,016  0,014  Telomerase stimulant
0,014  0,012  Prostacyclin agonist
0,082  0,082  ABCA1 expression enhancer

